Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Steinert disease].

Françoise Bouhour1, Muriel Bost, Christophe Vial

  • 1Service d'ENMG et pathologies neuromusculaires, Hôpital neurologique, Bron (69), France. francoise.bouhour@chu-lyon.fr

Presse Medicale (Paris, France : 1983)
|February 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply to "Sural/Radial Amplitude Ratio in Non-Length-Dependent Neuropathy (NLDN): A Call for More Standardized Methodology and Further Evaluation of Distal NLDN".

Muscle & nerve·2026
Same author

Managing Pompe Disease and Enzyme Replacement Therapy During Pregnancy: Challenges and Considerations.

European journal of neurology·2026
Same author

Predictive Factors for Non-response to First Use of Polyvalent Intravenous Immunoglobulin in Generalised Myasthenia Gravis.

Neurology and therapy·2026
Same author

Clinical Features and Prognosis of SEPTIN9-Related Hereditary Neuralgic Amyotrophy.

European journal of neurology·2026
Same author

Real-world effectiveness and safety of zilucoplan in patients with anti-AChR myasthenia gravis: A retrospective cohort study in France.

Journal of neuromuscular diseases·2026
Same author

Multiple Mononeuropathy Secondary to Parvovirus B19 Infection: A Case Series.

European journal of neurology·2026
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Steinert disease, or myotonic dystrophy type 1, is a frequent adult-onset muscular dystrophy affecting multiple organs. Diagnosis involves genetic testing, and management requires multidisciplinary care due to variable expression and potential complications.

Area of Science:

  • Neurology
  • Genetics
  • Dermatology

Context:

  • Steinert disease (myotonic dystrophy type 1) is the most common adult-onset muscular dystrophy.
  • It presents with myotonia and diverse multiorgan damage, including muscle weakness, cardiac issues, cataracts, endocrine dysfunction, sleep disturbances, and baldness.

Purpose:

  • To provide a comprehensive overview of myotonic dystrophy type 1.
  • To highlight diagnostic criteria, genetic transmission, and clinical variability.
  • To emphasize the importance of multidisciplinary management and genetic counseling.

Summary:

  • Diagnosis is confirmed via molecular genetic identification of abnormalities at the 19q13-2 locus.
  • The condition follows autosomal dominant inheritance with potential anticipation, leading to earlier and more severe disease in offspring.

Related Experiment Videos

  • Management involves annual multidisciplinary follow-up, crucial due to the disease's progressive nature and potential for rapid deterioration.

    • Impact:

    • Understanding the genetic basis and variable expression is key for effective genetic counseling.
    • Prenatal diagnosis is recommended, particularly for maternal transmission, due to severe neonatal forms.
    • Reduced life expectancy is linked to cardiac and pulmonary complications, underscoring the need for vigilant monitoring.